Rare diseases
Investigational molecules
Locations
Back to Germany11 clinical trials in Naunhof, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyStudy on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
GermanySARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
GermanyPhase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
GermanyEfficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes
GermanyStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GermanyEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
GermanyA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
GermanyStudy of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo
GermanyStudy on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler
GermanyStudy on Hydroxycarbamide Resistance in Patients with Polycythemia Vera Identified by AI Predictors
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Irritable Bowel Syndrome treatment approaches, specifically evaluating the effectiveness of probiotic therapy using living bacteria for patients with diarrhea-predominant IBS.
Research aims to improve quality of life for IBS patients through innovative bacterial treatments.
Groundbreaking research exploring medical cannabis aerosol applications for treating diabetic peripheral neuropathic pain, with a focus on precise dosing and delivery methods.
Studies aim to establish effective pain relief protocols for chronic neuropathic conditions.
Advanced studies utilizing artificial intelligence to predict treatment resistance in polycythemia vera patients, focusing on hydroxyurea therapy effectiveness.
Integration of machine learning technologies to enhance treatment outcomes in hematological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
